@article{AMJ4381,
author = {Thanakorn Pungsrinont and Aria Baniahmad},
title = {Targeting the glucocorticoid receptor for a combinatory treatment strategy for castration resistant prostate cancer?},
journal = {AME Medical Journal},
volume = {3},
number = {3},
year = {2018},
keywords = {},
abstract = {Prostate cancer (PCa) ranks the most frequently diagnosed male cancer in the Western world (1). It develops first as an androgen-dependent tumor in which androgens promote the growth of the PCa cells. Eventually, it develops into a castration resistant stage that no longer depends on androgens.},
issn = {2520-0518}, url = {https://amj.amegroups.org/article/view/4381}
}